trolamine salicylate
trolamine salicylate structure
|
Common Name | trolamine salicylate | ||
|---|---|---|---|---|
| CAS Number | 2174-16-5 | Molecular Weight | 287.309 | |
| Density | 1.209 g/mL at 25 °C | Boiling Point | 335.4ºC at 760mmHg | |
| Molecular Formula | C13H21NO6 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 113 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
| Name | triethanolamine salicylate |
|---|---|
| Synonym | More Synonyms |
| Density | 1.209 g/mL at 25 °C |
|---|---|
| Boiling Point | 335.4ºC at 760mmHg |
| Molecular Formula | C13H21NO6 |
| Molecular Weight | 287.309 |
| Flash Point | 113 °C |
| Exact Mass | 287.136902 |
| PSA | 121.46000 |
| Vapour Pressure | 8.38E-06mmHg at 25°C |
| Index of Refraction | n20/D 1.509 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R20/21/22 |
| Safety Phrases | S24/25-S36-S26 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2922199090 |
|
~98%
trolamine salicylate CAS#:2174-16-5 |
| Literature: Adamovich; Mirskov; Mirskova; Voronkov Russian Chemical Bulletin, 2012 , vol. 61, # 6 p. 1260 - 1261 Izv. Akad. Nauk, Ser. Khim., 2012 , vol. 61, # 6 p. 1246 - 1247,2 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2922199090 |
|---|---|
| Summary | 2922199090. other amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies.
Br. J. Clin. Pharmacol. 46(1) , 29-35, (1998) The penetration of active ingredients from topically applied anti-inflammatory pharmaceutical products into tissues below the skin is the basis of their therapeutic efficacy. There is still controvers... |
|
|
Serum concentrations of salicylic acid following topically applied salicylate derivatives.
Ann. Pharmacother. 30(9) , 935-40, (1996) To compare the rate and extent of systemic salicylate absorption following single and multiple applications of two topically applied analgesics, one containing methyl salicylate and the other containi... |
|
|
Self promotion of deep tissue penetration and distribution of methylsalicylate after topical application.
Pharm. Res. 16(3) , 427-33, (1999) To determine how changes in cutaneous blood flow induced in-vivo by methylsalicylate (MeSA), compared to non-rubefacient triethanolamine salicylate (TSA), affected topical salicylate absorption and di... |
| Salicylic acid |
| triethanol-amine salicylate |
| Salicylic acid, compound with 2,2',2''-nitrilotriethanol (1:1) |
| trolamine salicylate |
| EINECS 218-531-3 |
| 2-Hydroxybenzoic acid - 2,2',2''-nitrilotriethanol (1:1) |
| Benzoic acid, 2-hydroxy-, compd. with 2,2',2''-nitrilotris[ethanol] (1:1) |
| 2-Hydroxybenzoic acid, compd. with 2,2',2''-nitrilotris(ethanol) (1:1) |
| MFCD00082325 |
| QVR BQ &Q2N2Q2Q |
| Q2N2Q2Q &QVR BQ |
| Triethanolamine salicylate |
| salicylic acid,compound with 2,2',2''-nitrilotriethanol (1:1) |
| TEA-Salicylate |